Smoking Cessation Aids Market Scope And Analysis

Report Code : TIPRE00023325
Category : Life Sciences

Status : Published
No. of Pages : 156

Buy Now

Smoking Cessation Aids Market Scope and Key Players Analysis by 2028

Buy Now

Smoking Cessation Aids Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 23.41 Billion
Market Size by 2028	US$ 64.03 Billion
Global CAGR (2021 - 2028)	15.5%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Product Nicotine Replacement Therapy Drugs Electronic Cigarettes By End-User Hospital Pharmacies Online Channel Retail Pharmacies Other End Users
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Pfizer Inc GlaxoSmithKline plc Dr Reddy s Laboratories Johnson and Johnson Services Inc Cipla Inc Perrigo Company plc Bausch Health Companies Inc Glenmark NJOY

Smoking Cessation Aids Market – by Product

Nicotine Replacement Therapy
Drugs
Electronic Cigarettes
Others

Smoking Cessation Aids Market – by End User

Hospital Pharmacies
Online Channel
Retail Pharmacies
Others

Smoking Cessation Aids Market – by Geography

North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East &Africa
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America

Company Profiles

Pfizer Inc.
GlaxoSmithKline plc.
Dr. Reddy's Laboratories
Johnson and Johnson Services, Inc.
Cipla Inc.
Perrigo Company plc
Bausch Health Companies Inc.
Glenmark
NJOY
Juul Labs